Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT06535802
Eligibility Criteria:
Inclusion Criteria:
* AIM 1: iCCaRE Consortium consumer advocates
* Clinicians who are part of the Translational Research \& Clinical Intervention Services (TRaCIS)
* AIM 2 ALPHA TESTING: iCCaRE consumer advocates \[2 Community Advisory Board (CAB) and 1 non-CAB\]
* AIM 2 BETA TESTING-PATIENTS:
* An African American/Black male
* A patient who has been diagnosed with prostate cancer in Florida at any time in their life, and/or within the previous 6 months has had an abnormal Prostate-Specific Antigen (PSA) lab value and/or Digital Rectal Examination (DRE)
* Minimum age of 30 years old
* Consent to participating in the intervention
Exclusion Criteria:
* AIM 2 BETA TESTING-PATIENTS:
* Patients who are not African American/Black males
* Patients not diagnosed with prostate cancer in Florida at any time in their life, or within the previous 6 months has not had a normal PSA lab value and/or DRE
* Older than 80 years old
* Are not willing to consent
Healthy Volunteers:
True
Sex:
ALL
Maximum Age:
80 Years
Study:
NCT06535802
Study Brief:
Protocol Section:
NCT06535802